Cargando…

Correction: The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab

Detalles Bibliográficos
Autores principales:	Magnes, T., Melchardt, T., Hufnagl, C., Weiss, L., Mittermair, C., Neureiter, D., Klieser, E., Rinnerthaler, G., Roesch, S., Gaggl, A., Greil, R., Egle, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096332/ https://www.ncbi.nlm.nih.gov/pubmed/30659276 http://dx.doi.org/10.1038/s41397-019-0073-5

Ejemplares similares

Prognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapy
por: Magnes, Teresa, et al.
Publicado: (2017)

CYP39A1 polymorphism is associated with toxicity during intensive induction chemotherapy in patients with advanced head and neck cancer
por: Melchardt, Thomas, et al.
Publicado: (2015)

Prognostic and Predictive Factors in Advanced Head and Neck Squamous Cell Carcinoma
por: Magnes, Teresa, et al.
Publicado: (2021)

Association of FCGR2A and FCGR2A-FCGR3A haplotypes with susceptibility to giant cell arteritis
por: Morgan, Ann W, et al.
Publicado: (2006)

Update on squamous cell carcinoma of the head and neck: ASCO annual meeting 2017
por: Magnes, Teresa, et al.
Publicado: (2017)

FCGR2A and FCGR3A polymorphisms and clinical outcome in metastatic colorectal cancer patients treated with first-line 5-fluorouracil/folinic acid and oxaliplatin +/- cetuximab
por: Kjersem, Janne B, et al.
Publicado: (2014)

Anti-Hu Antibody Associated Paraneoplastic Cerebellar Degeneration in Head and Neck Cancer
por: Huemer, Florian, et al.
Publicado: (2015)

Postoperative chemoradiotherapy with cisplatin is superior to radioimmunotherapy with cetuximab and radiotherapy alone: Analysis of the Austrian head and neck cancer registry of the AGMT
por: Magnes, Teresa, et al.
Publicado: (2021)

FCGR2A, FCGR3A polymorphisms and therapeutic efficacy of anti-EGFR monoclonal antibody in metastatic colorectal cancer
por: Ying, Hou-Qun, et al.
Publicado: (2015)

Association of FCGR3A and FCGR3B haplotypes with rheumatoid arthritis and primary Sjögren's syndrome
por: Mackie, S, et al.
Publicado: (2005)

FCGR2A and FCGR3A Genotypes in Human Immunodeficiency Virus Mother-to-Child Transmission
por: Milligan, Caitlin, et al.
Publicado: (2015)

Clonal evolution in diffuse large B-cell lymphoma with central nervous system recurrence
por: Magnes, T., et al.
Publicado: (2021)

Association of FCGR2A/FCGR3A variant rs2099684 with Takayasu arteritis in the Han Chinese population
por: Chen, Si, et al.
Publicado: (2016)

FCGR2A Could Function as a Prognostic Marker and Correlate with Immune Infiltration in Head and Neck Squamous Cell Carcinoma
por: Dai, Yongmei, et al.
Publicado: (2021)

FCGR3A and FCGR2A Genotypes Differentially Impact Allograft Rejection and Patients' Survival After Lung Transplant
por: Paul, Pascale, et al.
Publicado: (2019)

Association of FCGR3A and FCGR3B Copy Number Variations With Systemic Lupus Erythematosus and Rheumatoid Arthritis in Taiwanese Patients
por: Chen, Ji-Yih, et al.
Publicado: (2014)

Influence of the FCGR2A rs1801274 and FCGR3A rs396991 Polymorphisms on Response to Abatacept in Patients with Rheumatoid Arthritis
por: Márquez Pete, Noelia, et al.
Publicado: (2021)

Associations of Fc gamma receptor (FcgR2a, FcgR3a and FcgR2c) genotype with outcome in metastatic renal cell carcinoma (mRCC) patients receiving high dose interleukin 2 (HD-IL2)
por: Erbe, Amy K, et al.
Publicado: (2015)

Copy number variation of FCGR genes in etiopathogenesis of sarcoidosis
por: Typiak, Marlena, et al.
Publicado: (2017)

Spatial Heterogeneity in Large Resected Diffuse Large B-Cell Lymphoma Bulks Analysed by Massively Parallel Sequencing of Multiple Synchronous Biopsies
por: Magnes, Teresa, et al.
Publicado: (2021)

Single Nucleotide Polymorphism rs10919543 in FCGR2A/FCGR3A Region Confers Susceptibility to Takayasu Arteritis in Chinese Population
por: Qin, Fang, et al.
Publicado: (2016)

Messenger RNA of FCGR3A and FCGR3B Genes as Monitoring Markers of Clear Cell Renal Adenocarcinoma (a Pilot Study)
por: Alyasova, A.V., et al.
Publicado: (2022)

A Comparison of Assays for Accurate Copy Number Measurement of the Low-Affinity Fc Gamma Receptor Genes FCGR3A and FCGR3B
por: Haridan, Umi Shakina, et al.
Publicado: (2015)

Copy number, linkage disequilibrium and disease association in the FCGR locus
por: Niederer, Heather A., et al.
Publicado: (2010)

CNVrd, a Read-Depth Algorithm for Assigning Copy-Number at the FCGR Locus: Population-Specific Tagging of Copy Number Variation at FCGR3B
por: Nguyen, Hoang tan, et al.
Publicado: (2013)

Frequency of FCGR3B Alleles in Thai Blood Donors
por: Kaset, Chollanot, et al.
Publicado: (2013)

Polymorphism of FCGR3A gene in chronic beryllium disease
por: Liu, Bing, et al.
Publicado: (2018)

Comparative Analysis of FCGR Gene Polymorphism in Pulmonary Sarcoidosis and Tuberculosis
por: Typiak, Marlena, et al.
Publicado: (2023)

Protective effects of FCGR2A polymorphism in invasive pneumococcal diseases
por: Bouglé, A, et al.
Publicado: (2012)

Alignment-free genomic sequence comparison using FCGR and signal processing
por: Lichtblau, Daniel
Publicado: (2019)

FCGR2C: An emerging immune gene for predicting sepsis outcome
por: Liu, Si, et al.
Publicado: (2022)

Analysis of Fcγ receptor haplotypes in rheumatoid arthritis: FCGR3A remains a major susceptibility gene at this locus, with an additional contribution from FCGR3B
por: Morgan, Ann W, et al.
Publicado: (2006)

Low Expression of miR-20a-5p Predicts Benefit to Bevacizumab in Metastatic Breast Cancer Patients Treated within the TANIA Phase III Trial
por: Rinnerthaler, Gabriel, et al.
Publicado: (2020)

Liver toxicity during temozolomide chemotherapy caused by Chinese herbs
por: Melchardt, Thomas, et al.
Publicado: (2014)

FCGR2B and FCRLB Gene Polymorphisms Associated with IgA Nephropathy
por: Zhou, Xu-jie, et al.
Publicado: (2013)

Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclones
por: Melchardt, Thomas, et al.
Publicado: (2016)

High Affinity Allele for the Gene of FCGR3A Is Risk Factor for HIV Infection and Progression
por: Poonia, Bhawna, et al.
Publicado: (2010)

FCGR3A: A new biomarker with potential prognostic value for prostate cancer
por: Zha, Zeyu, et al.
Publicado: (2022)

FCGR2A Promoter Methylation and Risks for Intravenous Immunoglobulin Treatment Responses in Kawasaki Disease
por: Kuo, Ho-Chang, et al.
Publicado: (2015)

Assessment of the Clinical Heterogeneity of Kawasaki Disease Using Genetic Variants of BLK and FCGR2A
por: Sim, Bo Kyung, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ki5njfi94csmro7jhtbsmmrhbh